StonvexLoading…
StonvexStonvexStonvexCore line items from TALO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.78B | $1.97B | $1.46B | $1.65B |
Operating Income | $-560.28M | $172.93M | $209.79M | $736.12M |
Net Income | $-494.29M | $-76.39M | $187.33M | $381.92M |
EPS (Diluted) | $-2.82 | $-0.44 | $1.55 | $4.56 |
Total Assets | $5.55B | $6.19B | $4.82B | $3.06B |
Total Liabilities | $3.38B | $3.43B | $2.66B | $1.89B |
Cash & Equivalents | $362.81M | $108.17M | $33.64M | $44.15M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 175.14M | 175.60M | 120.75M | 82.57M |